Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
11/2001
11/21/2001EP1154771A1 Nitrosated and nitrosylated proton pump inhibitors, compositions and methods of use
11/21/2001EP0918774B1 Androgen receptor modulator compounds and methods
11/21/2001EP0873340B1 Heterocyclic substituted cyclopentane compounds
11/21/2001EP0833638B1 USE OF IMIDAZO 1,5-a]QUINOLONES AS NEUROPROTECTIVE AGENTS
11/21/2001EP0784622B1 Naphthyridinone derivatives
11/21/2001EP0745081B1 indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase
11/21/2001CN1323308A New compounds
11/21/2001CN1323307A 1H-imidazopyridine derivatives
11/21/2001CN1323306A Naphthyridine derivatives
11/21/2001CN1323297A Pyridazinone derivatives
11/21/2001CN1323209A Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase
11/21/2001CN1322715A Process for producing piperidine compound
11/21/2001CN1322526A Compound for treating female sexual dysfunction
11/21/2001CN1075073C Hetero-aromatic ring substituted phenyloxazolidinone antimicrobials
11/21/2001CN1075061C Heterocyclylbenzonitriles
11/21/2001CN1074926C Antiarrhythmic benzodiazepines
11/21/2001CN1074902C Fungicidal active compound composition
11/20/2001US6320048 Esterification of tetrahydro-9-hydroxy-4h-pyrido(1,2-a) pyrimidin-4-one derivative, separating diastereomeric esters by chromatography, and hydrolysis conversion to corresponding enantiomorphs
11/20/2001US6319930 Substituted dimeric compounds
11/20/2001CA2176668C Heterocyclic spiro compounds, process for preparing the same and pharmaceutical compositions containing them
11/19/2001CA2308994A1 Neuroprotective compounds
11/15/2001WO2001085732A1 Pyridobenzodiazine derivatives and processes for the preparation thereof
11/15/2001WO2001085731A1 A PROCESS FOR THE PREPARATION OF ANTI-PSCHOTIC 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2,-a]pyrimidin-4-one
11/15/2001WO2001085730A1 Pyrido' 1,2-alpha pyrazine and piperidine derivatives as ligands for the neuropeptide y y5 receptor
11/15/2001WO2001085729A1 Novel vitronectin receptor antagonists
11/15/2001WO2001085714A1 Amino substituted dibenzothiophene derivatives for the treatment of disorders mediated by the np y5 receptor
11/15/2001WO2001085695A1 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
11/15/2001WO2001085694A2 Substituted diamide derivatives useful as motilin antagonists
11/15/2001WO2001085686A2 Multicyclic compounds and the use as inhibitors of parp, vegfr2 and mlk3 enzymes
11/15/2001WO2001085170A1 Peptide deformylase inhibitors
11/15/2001WO2001085095A2 Chiral fluoroquinolizinone arginine salt forms
11/15/2001WO2001058427A8 Particulate composition, method for producing said composition and use of the same
11/15/2001WO2001040185B1 Compounds, compositions, and methods for stimulating neuronal growth and elongation
11/15/2001WO2001034601A3 Imidazopyridine derivatives as phosphodiesterase vii inhibitors
11/15/2001US20010041801 Prevent human retroviral reproduction, infections
11/15/2001US20010041728 With thiourea, thioamide, or dithiocarbamate functionality; (S)-N-(((3-(3-fluoro-4-morpholinyl)phenyl)-2-oxo-5 -oxazolidinyl)methyl)thioacetamide for example; treats multiple-resistant staphylococci
11/15/2001US20010041726 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
11/15/2001US20010041715 Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
11/15/2001US20010041711 8-(4,4-Bis(p-fluorophenyl)butyl)-1-phenyl-1,3,8-triazospiro(4.5) decan-4-one, for example; treating pain with reduced side effects of opioid analgesics; affinity for opioid receptor-like (ORL1) receptor
11/15/2001US20010041703 Which are growth hormone secretogogues and increase the level of endogenous growth hormone; treating osteoporosis, congestive heart failure, frailty associated with aging, obesity; accelerating bone fracture repair
11/15/2001DE10022369A1 Verfahren zur Herstellung von Piperidinen Process for the preparation of piperidines
11/15/2001CA2409758A1 Novel multicyclic compounds and the use thereof
11/15/2001CA2408486A1 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
11/15/2001CA2408293A1 Novel vitronectin receptor antagonists
11/15/2001CA2408288A1 Novel substituted diamine derivatives useful as motilin antagonists
11/15/2001CA2408236A1 Peptide deformylase inhibitors
11/15/2001CA2406634A1 Amino substituted dibenzothiophene derivatives for the treatment of disorders mediated by the np y5 receptor
11/15/2001CA2403264A1 Chiral fluoroquinolizinone arginine salt forms
11/14/2001EP1153918A1 Process for the preparation of piperidines from pyridines using catalytic hydrogenation
11/14/2001EP1153050A1 Amino-ketone solid support templates
11/14/2001EP1098883A4 Process for preparing heterocyclic compounds
11/14/2001EP0904081B1 Aqueous suspensions of 9-hydroxyrisperidone fatty acid esters
11/14/2001EP0847400B1 Polymorphs of the prodrug 6-n-(l-ala-l-ala)-trovafloxacin
11/14/2001EP0763037B1 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USE THEREOF
11/14/2001EP0717743B1 N-ARYL 1,2,4]TRIAZOLO 1,5-a]PYRIDINE-2-SULFONAMIDE HERBICIDES
11/14/2001EP0706527B1 Substituted spiroheterocyclic 1h-3-arylpyrrolidine-2,4-dione derivatives, methods of preparing them and their use as pest-control agents
11/14/2001CN1322204A Oxazolidinone antibacterial agents having thiocarbonyl functionality
11/14/2001CN1322133A Vitronectin receptor antagonists
11/14/2001CN1321642A Cynanchun komarovii extract and its application
11/13/2001USRE37449 Including 1,4-reduction of dimeric iminium intermediate to an enamine by reaction with a 1,4-dihydropyridine; oxidative transformation of the product to a second iminium intermediate; reduction of the second intermediate
11/13/2001US6316629 Process for the preparation of 2,3-pyridinedicarboximides
11/13/2001US6316482 Benzamide derivatives having a vasopressin antagonistic activity
11/13/2001US6316464 P38 MAP kinase inhibitors
11/13/2001US6316457 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
11/13/2001US6316449 Chemokine receptor antagonists
11/13/2001US6316438 Fused pyridopyridazine inhibitors of cGMP phosphodiesterase
11/13/2001US6316429 Enzyme inhibitors modulate the activity of protein kinases and therefore are expected to be useful in the prevention and treatment of protein kinase related cellular disorders such as cancer.
11/08/2001WO2001083484A1 Pyrano, piperidino, and thiopyrano compounds and methods of use
11/08/2001WO2001083483A1 (5R)-(METHYLAMINO)-5,6-DIHYDRO-4H-IMIDAZO[4,5,1-ij]QUINOLINE-2(1H)-THIONE
11/08/2001WO2001083482A1 Dna alkylating agent and activation thereof
11/08/2001WO2001083481A1 Imidazopyridine derivatives
11/08/2001WO2001083480A2 Dihydropyridine compounds and methods of use
11/08/2001WO2001083479A2 Process for the preparation of pyrazolopyridine derivatives
11/08/2001WO2001083472A1 Muscarinic agonists
11/08/2001WO2001083460A1 Cyclic compounds
11/08/2001WO2001083459A2 Uracil substituted phenyl sulfamoyl carboxamides
11/08/2001WO2001083427A1 PPARη MODULATORS
11/08/2001WO2001082925A1 Melanin concentrating hormone antagonists
11/08/2001WO2001032632A3 Pharmaceutically active 4-substituted pyrimidine derivatives
11/08/2001US20010039347 Heating a mixture of caprolactone and p-methoxybenzylamine; cyclization
11/08/2001US20010039286 Especially substance P
11/08/2001US20010039284 Acetylcholine enhancers
11/08/2001CA2407594A1 Muscarinic agonists
11/08/2001CA2407587A1 Ppar.gamma. modulators
11/08/2001CA2407317A1 Dihydropyridine compounds and methods of use
11/08/2001CA2407231A1 Cyclic compounds
11/08/2001CA2404936A1 (5r)-(methylamino)-5,6-dihydro-4h-imidazo¬4,5,1-ij|quinoline-2(1h)-thione
11/08/2001CA2346529A1 Process for preparing piperidines
11/07/2001EP1150985A1 A reagent system and method for increasing the luminescence of lanthanide(iii) macrocyclic complexes
11/07/2001EP1150965A1 Benzazepine derivatives as alpha-v integrin receptor antagonists
11/07/2001EP0843679B1 1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives
11/07/2001CN1321157A Substd. imidazo [1,2] azines as selective inhibitors of COX-2
11/07/2001CN1321150A Amide derivs. useful as inhibitors of production of cytokines
11/07/2001CN1320426A Compound for treatment of female sexual dysfuction
11/07/2001CN1320375A Herbicidal synergic composition and method for controlling weed
11/07/2001CN1320374A Herbicidal synergic composition and method for controlling weed
11/07/2001CN1320373A Herbicidal synergic composition and method for controlling weed
11/06/2001US6313300 Oxidation process for preparing quinacridone pigments
11/06/2001US6313298 Spiro-indolines as Y5 receptor antagonists
11/06/2001US6313292 Process for preparing 4,6-disubstituted pyrido[3,4-d]pyrimidines
1 ... 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 ... 646